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Abstract
Background: Mental disorders in the perinatal period (PMD) can severely harm women and their children if not
detected early and treated appropriately. Even though mental health care is covered by health insurance and is
used widely by women in the perinatal period in Switzerland, it is not known if the care provided is meeting the
needs of the patients and is efficient in the view of health care professionals. The aim of this study is to identify
strengths, gaps and requirements for adequate mental health care in the perinatal period from the perspectives of
patients and care providers for a wide range of relevant mental disorders.
Methods: In the qualitative study we conduct (1) semi-structured single interviews with former PMD patients to
obtain narratives about their experiences and needs for health care for their condition. Women are included who
have been treated for PMD but are mentally stable at the time of the interview (n = 24). We will stratify the sample
by 4 clusters of relevant ICD-10 F-diagnoses, covering the most frequent and the most severe mental disorders. We
will further stratify the sample based on whether the women already had experience with psychiatric or
psychological health care or not before their last episode of PMD. We will also conduct (2) three interprofessional
focus groups with health and social care professionals involved in perinatal care, and a health insurance
representative. The focus groups will consist of 5–8 professionals. Data collection and thematic analysis will consider
Levesque’s et al. (2013) conceptual model on access to health care.
Discussion: The study will provide fundamental data on the experiences and perspectives about perinatal mental
health care from user and provider perspectives. The study will generate the evidence base needed to develop models
of integrated, coordinated, patient- and family-centred care that is accessed by women with various types of PMD.
Trial registration: The study was registered on ClinicalTrials.gov in November 2019 under the identifier NCT04185896.
Keywords: Perinatal, Mental disorder, Health care, Access to health care, User perspective, Provider perspective,
Qualitative study
Plain English summary
Background
Up to one in five women may have a mental disorder dur-
ing pregnancy or in the first year after delivery. It is crucial
to identify and treat these women early and appropriately
to avoid adverse consequences like birth complications,
persistent mental illness or child development problems. In
Switzerland, many pregnant or postnatal women receive
mental health care, but we do not know whether the health
care is timely, accessible and appropriate. The aim of this
study is to identify the requirements for adequate mental
health care during pregnancy and after childbirth.
Methods
We conduct individual interviews with women about
their experiences with health care during pregnancy or
after childbirth. We interview women with different
mental disorders to cover a broad range of needs toward
health care. We take into account whether the women
had experience with mental health care from earlier
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phases of life. We also conduct group interviews with
health and social care professionals. We categorize the
statements of the interviewees into topics that are rele-
vant to health care provision of affected women. An
established theory about access to health care is consid-
ered in the analysis.
Discussion
The study will provide fundamental information to im-
prove health care to women with mental health prob-
lems during pregnancy and after birth. The conclusions
of the study will help to improve mental health care for
this vulnerable population.
Background
Prevalence and consequences of perinatal mental
disorders
Perinatal mental disorders (PMD) are mental and behav-
ioural disorders that occur during pregnancy or in the first
year postpartum. PMD may affect up to 20% of women [1,
2] and can severely harm women and their children if not
detected and treated appropriately. For example, women
suffering from PMD have poorer obstetric outcomes [3, 4]
and severe PMD are associated with a 70-fold increased
suicide risk in the first year post-partum [5]. In an Austra-
lian study, suicide and accidental injury accounted for 62%
of deaths of women in this period and injuries categorized
as accidental might be intentional [6]. Children of mothers
with PMD are at risk of early psychopathology and per-
sistent emotional, behavioural, or cognitive problems [4,
7]. In-adequate treatment of PMD were estimated to cost
the UK about £8.1 billion in direct and indirect costs – al-
most £10′000 per birth [8]. Most of the costs (72%) came
from the adverse consequences of PMD for children. The
potential of PMD to severely harm women and their chil-
dren and high follow-up costs call for specific interven-
tions to facilitate service utilization and improve mental
health care for this vulnerable group.
Mental health care in the perinatal period
Supply and use of mental health care
In high-income-countries like Switzerland, general men-
tal health services usually are abundant, covered by
health insurance, and most services can be accessed dir-
ectly [9]. Nevertheless, more than 50% of people in the
general population with mental disorders remain un-
treated [10, 11]. In the perinatal population of women,
rates of undiagnosed women might be even higher [12,
13] and treatment rates may be significantly lower than
in non-pregnant cohorts [12, 14].
In a population based study we found that 16.7% of
perinatal women per year used mental health services at
least once [15]. Women with PMD seemed to prefer
out-patient settings and the most frequent treatment for
PMD was psychotropic medication. Up to 10% of
women had used mental health care already before preg-
nancy [15]. The fact that half of these women stopped
using mental health services during pregnancy is con-
cerning because they had no professional support to
help them adjust to the emotional, physical and social
challenges of the perinatal period. Only 1% of perinatal
women received mental health care in obstetric hospi-
tals. Freelance midwives visiting women at home during
post-partum care recorded PMD rarely, too [15]. It ap-
pears that there are significant health care gaps and the
care provided might not be timely, adequate, or efficient.
Barriers to appropriate health care
Barriers that prevent perinatal women from accessing
mental health services are complex and interlinking [16].
Specific barriers include stigma related to mental illness
[11, 17–19]. Women do not seek help because they feel
ashamed or embarrassed to admit to mental illness in this
period of life [13, 18]. Women may avoid mental health
services because mothers with severe mental disorders are
seen as incapable of caring for their children [20]. Among
British women who experienced postpartum depression,
30% reported that they never spoke to health professionals
about their symptoms [21]. The acceptability of pharma-
cotherapy may be lower during pregnancy and breastfeed-
ing, and when psychotherapy is available, it may not be
accessible quickly enough [12, 13, 17]. Lack of affordable
childcare may pose another barrier [13]. Some women
normalize their symptoms and misunderstand them as an
adjustment to motherhood, or may not report them be-
cause they are unfamiliar with mental illness and possible
treatments [13, 20]. Similar barriers might exist in the so-
cial environment of women with PMD. Friends and family
might tend do normalize symptoms and may not support
women who seek help [18]. Some women report that their
family, friends, or partners expect women to be happy in
this period of life [18].
On the provider side, systematic screening for PMD is
missing, and structural or procedural barriers in the
health care system prevail [19, 22, 23]. For example,
Swiss psychiatric and gynaecological societies have not
yet developed guidelines for PMD care. We could not
find guidelines from cantons, hospitals or professional
associations via search engines or literature databases.
Specialized inpatient care in obstetric hospitals is rare in
Switzerland [9] and obstetricians and midwives, who
provide most of the care for perinatal women in
Switzerland, rarely feel sufficiently trained to deal with
women at risk or with symptoms of PMD [24, 25].
Women might need seamless transitions and good com-
munication between services or units, but models of care
can be disconnected [8, 13, 19, 22]. For example, when
women are screened in obstetric care, an acceptable and
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timely intervention may not be available in the same set-
ting [13]. Personnel in the obstetric setting are not
equipped to deal with mental illness [24, 26, 27], and
may not know about pharmaceuticals that do not harm
the embryo, foetus, or new-born. Continued support can
only be guaranteed when multidisciplinary perinatal ser-
vices include expertise in maternity services and offer
mental health treatment within the unit.
Theoretical framework
Barriers to access to health care significantly contribute
to in-adequate care. Levesque et al. [28] define access to
health care as “the opportunity to reach and obtain ap-
propriate health care services in situations of perceived
need for care”. Access is determined by the intersection
of personal (user) and institutional (provider) traits that
can interfere with or support the “pathway of utilisa-
tion”. They define five consecutive steps to gain access
to care; in the context of PMD these might be 1. the
need for PMD treatment (e.g. risk factors, vulnerability
to PMD; symptoms of PMD), 2. the ability to recognize
health care needs and desired care, 3. seeking care for
PMD, 4. reaching and obtaining PMD care; and, 5. re-
ceiving health care services appropriate to the needs of
individual patients with PMD. The provider side contrib-
utes to the interface supply-related determinants of ac-
cessibility, i.e. approachability, acceptability, availability
and accommodation, affordability and appropriateness.
On the user side the abilities to perceive, seek, reach,
pay for, and engage with health care services prevail
[28]. We use this framework to capture experiences and
needs of former PMD patients and health professionals
with regards to access to perinatal mental health care.
Research gaps
Mental disorders in the perinatal phase are widespread
and can cause serious harm to women, their new-borns
and families. In Switzerland mental health care is cov-
ered by mandatory insurance and many perinatal women
use mental health care, mainly in non-obstetric out-
patient settings where they are treated by mental health
specialists (psychiatrists, psychologists) and primary care
physicians [15]. It is not clear if this care meets the
needs of affected women, or if all women have full ac-
cess, as defined by Levesque et al. [28]. Studies have usu-
ally explored the needs of patients with postpartum
depression [21, 29–33], but not the possibly different
needs of women with other common or severe PMD like
anxiety disorders, drug abuse disorders, and psychotic
disorders. Since PMD carries a stigma [11, 34], many
women may not access health services and go untreated.
Specialized care for PMD is complex. It must be easily
accessible and patient-oriented. Women need to be able
to make informed decisions about suitable treatment
and consider benefits and adverse effects of medication
vs. psychotherapy. Inpatient psychiatric care has to re-
spect bonding and attachment processes.
There is so far little information on womens’ needs
and preferences for PMD health care and treatment.
Nor do we know the views of professionals involved in
perinatal health care what is required to adequately as-
sess and treat affected women.
Objectives
1. Identify the experiences and needs of PMD patients
regarding perinatal mental health care
2. Capture the perspectives of health professionals and
social care providers who care for perinatal women,
their children and families on perinatal mental
health care
3. Describe facilitators and barriers to perinatal mental
health care provision based on a conceptual model
of access to care
4. Extend the previous research focus on postnatal
depression to include a wide range of common and
severe PMDs so the diverse needs of women with
different PMD can be captured.
Methods/design
Aim of the study
The aim of this study is to gain basic insights into the
strengths, gaps and requirements for adequate mental
health care in the perinatal phase in a high-income
country. The study aims to gain a broad understanding
of the problem by combining the perspectives of both
patients and care providers for a wide range of relevant
mental disorders defined by the ICD-10 diagnoses.
Study design and setting
The study takes a qualitative explorative approach. It
uses single semi-structured interviews to capture experi-
ences and needs of 24 former PMD patients (part 1, user
perspective). We will conduct three focus group inter-
views based on a semi-structured interview guide to
gather experiences and perspectives of health profes-
sionals and social care providers on perinatal health care
for patients with PMD (part 2, provider perspective).
The study population of part 1 will be former patients
of a specialized gynecological-psychiatric consultation
service offered at the Psychiatric University Hospital of
Bern, Switzerland. Health and social care professionals
for part 2 will be recruited in Bern and in close-by can-
tons of Aarau, Solothurn and Basel.
Outcomes
Outcomes are narratives of experiences and perspectives
of former PMD patients and health and social care
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professionals. Further outcomes will be descriptions of
relevant barriers and facilitators to perinatal mental
health care. We also will describe recommendations for
perinatal mental health care.
As baseline characteristics of the sample of part 1 we
will assess quantitatively 1. current psychological burden
by the Brief Symptom Inventory [35] and 2. socio-
demographic parameters (supplementary Table 2, Add-
itional file 1). As baseline characteristics of the focus
group members we will assess their socio-demographic
parameters (supplementary Table 4, Additional file 1).
Sample
The study sample for part 1 consists in women with pre-
viously experienced PMD. The sample for part 2 are
health professionals and social care providers working
with perinatal women and having dealt with women with
PMD, and a health insurance delegate.
Women with former PMD
The sample size of women with former PMD will be
n = 24 (Fig. 1). This should be large enough to achieve
data saturation in the interviews. Data saturation is
achieved when no additional new information is gath-
ered in additional interviews. If data saturation would
not be achieved with 24 interviews, we would continue
sampling and conduct further interviews to achieve data
saturation.
Eligibility criteria We will include women with a his-
tory of PMD who meet the following criteria:
a) Have had PMD within the past 24 months before
the interview
b) Have recovered from acute PMD and are stable at
least 12 months before the interview;
c) Are considered able to share their experiences;
d) Are more than 18 years old
e) Speak and understand German.
f) Have received PMD diagnoses from one of the
following 4 groups of psychiatric disorders (ICD-10
Chapter V, F00-F99) [36]:
1. Mood (affective) disorders (F30-F39); Anxiety
disorders (F41); Reaction to severe stress, and
adjustment disorders (F43); and Obsessive-
compulsive disorder (F42);
2. Disorders of adult personality and behavior
(F60-F69; especially F60.3 Emotionally unstable
personality disorder);
3. Mental and behavioral disorders due to
psychoactive substance use (F10-F19; excluding
tobacco (F17) if it is the sole F-diagnosis of the
patient);
Fig. 1 Inclusion chart: 24 women with perinatal mental disorder (PMD) in their past perinatal period will be recruited for the study. All included
women are mentally stable for at least 12 months before the interview. Women who are pregnant again are excluded. For further inclusion or
exclusion criteria see text. *Number of women in these clusters may range between 0 and 3 because of possible difficulties in recruiting women
with these F-diagnoses who had experienced mental health care before pregnancy. **If the number of recruited women with previous mental
health care experience in this PMD - cluster is less than 3, we will recruit more women without previous experience in mental health care to
reach a total number of six women per cluster of ICD-10 diagnoses
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4. Psychosis (F20-F29 Schizophrenia, schizotypal
and delusional disorders).
Women will be grouped into 4 clusters of psychiatric
diagnoses (Fig. 1). The first cluster represents the most
frequent types of PMD, which are often co-morbid. Diag-
noses from cluster 2 are also frequent in the perinatal
period. Cluster 3 and 4 represent severe PMD requiring
different care. We will try to include six women to each
cluster of PMD; three of these women will have already
received mental health care before their last pregnancy,
and three of these women will not have received mental
health care before their last pregnancy. We define received
mental health care as any care that was provided by a
psychiatrist or by a psychological therapist.
Exclusion criteria We will exclude women who are
pregnant because physiological adaptations to pregnancy
might influence the emotional and mental well-being.
Health professionals and social care providers
For study part 2 we will conduct three interprofessional
focus groups with 6–8 participants each (total n = 18–
24). A minimum of 3 focus groups is needed to obtain
representative information [37]. We assume that our
sample size is large enough to achieve data saturation. If
data saturation would not be achieved after conducting
the three focus groups, we would conduct further focus
group interviews to achieve data saturation.
We will sample health care professionals and social care
providers who work with perinatal women in in- and
outpatient settings, and a health insurance delegate. Care
providers include gynecologists, medical primary care pro-
viders, pediatricians, neonatologists, psychiatrists, psychol-
ogists, nurses, midwives, social care providers (community
and hospital service) and community care nurses.
Eligibility criteria Health professionals and social care
providers will be included if they
a) Have professional experience of at least 2 years,
b) Have cared for at least two PMD patients the year
before the focus group, and
c) Understand and speak German.
Recruitment
Women with former PMD
Our study partners from the Bern University Hospital of
Psychiatry will support us in consecutively recruiting 24
women with former PMD. They will identify former
patients from their database and contact women who meet
the above inclusion criteria to ask them if they would be in-
terested in participating in the study and specifically in a
personal interview of about 2 h (including framing,
interview and filling in a short questionnaire to assess their
socio-economic background and the Brief Symptom Inven-
tory (BSI) [35] at any location the women feels convenient
with. If a woman is interested in participating, our study
partners will ask her to agree in writing that the study part-
ner can forward her contact information and diagnosis to
the study coordinators at the Bern University of Applied
Sciences. If the woman agrees to have her contact informa-
tion forwarded to the study coordinators, the local study
partners will provide us with her contact data and previous
PMD ICD10-F-diagnosis. Afterwards, the study team will
give the interested woman standardized written informa-
tion describing the purpose and benefits of the study, and
the time and effort required to participate. A member of
the project team will also contact her by phone, answer any
open questions and, if the woman is still interested, make
an appointment for the interview. The woman may choose
to be interviewed at home, in a conference room at Bern
University of Applied Sciences, or in another place she pre-
fers. If a woman decides not to participate in the study, we
will delete all the information we received about her.
Health professionals and social care providers
We will recruit health professionals and social care pro-
viders in Bern, Aarau and Basel through professional asso-
ciations, communities, and professional networks of the
study team. The study team will contact potential partici-
pants with written standardized information about the
purpose and benefits of the study and the time and effort
participation will require. Health professionals and social
care providers will be invited to participate in one of three
focus groups conducted in Bern.
We will analyze the first 3–4 individual interviews with
women ad interim analysis and will use any relevant in-
formation to update the focus group semi-structured
interview guide.
Data collection
Individual interviews with women who had PMD
We will conduct semi-structured individual interviews
(INI) to capture the personal experiences and needs of
women who suffered from PMD. We will use a semi-
structured interview guide which will include open-
ended questions informed by the literature, experience
of the study team and a test run with a previous PMD
patient in our net works. The interview guide will be
framed by the conceptual model of access to health care
by Levesque et al. [28]. We will pilot the guide with the
first two women in the study and revise it for further in-
terviews. The interviews will be conducted by trained
health professionals (nurse, psychologist or midwife) and
will be audio-recorded for transcription and analysis.
The interviewer first informs the participant about the
purpose and benefits of the study and obtains written
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informed consent. The participants next will fill in the BSI
[35] to assess psychological distress during the past 7 days
before the interview. Then the semi-structured interview
will be conducted (supplementary Table 1, Additional file
1). After the interview, participants will be asked to
complete a survey to collect socio-demographic data that
describes women’s characteristic (supplementary Table 2,
Additional file 1). Welcome and introduction to the inter-
view, filling in questionnaires and information at the end
of the interview will last 60–90min, depending on the
length of the narrative of the participant.
Focus groups with professionals
We will conduct focus groups with health professionals,
social care providers, and delegates of a health insurance
company to gather rich information about their range of
experiences and perspectives. Our study has an interdis-
ciplinary focus, so we will ensure a mix of participants
from all relevant disciplines. Interactive discussions among
participants should reveal similarities and differences in
the experiences of participants. Two members of the re-
search group will guide the focus groups. One person will
moderate the interview and one person will ensure the
groups run smoothly. Before the focus group interview,
the moderator will inform the participants about the pur-
pose and procedure of the focus group interviews. When
written informed consent is obtained of all participants,
the focus group interview will begin based on a semi-
structured questionnaire. It will include questions in-
formed by the literature, and draw on the conceptual
model of access to care of Levesque et al. [28], as well as
on the expertise of the research team. We will ask inter-
view questions in the style of Krueger and Casey [37]. We
will continually update the interview guide for the focus
groups, based on findings from our individual interviews
with former PMD patients so we can generate user-driven
questions [38]. The interview guide for the focus group
will also be adapted, based on experiences with the first
focus group interview. The focus groups will last about 90
min, depending on the length of the contributions of the
participants. A draft of the interview guide is provided
(supplementary Table 3, Additional file 1).
Withdrawal and discontinuation
Participants of the semi-structured interviews and the
focus groups will be informed about their opportunity to
withdraw from informed consent at any time and with-
out any consequences. All collected personal informa-
tion will be deleted if a participant withdraws consent to
participate at any point during the study.
Data recording and source data
The semi-structured interviews with former PMD pa-
tients and the focus group interviews with health
professionals will be audio-recorded and transcribed ver-
batim. We will use the software program F4transkript
(f4transkript Version 6.2.4 Edu, dr.dresing & pehl
GmbH, Marburg, Germany) for the transcription of the
recordings. Data will be analyzed using ATLAS.ti soft-
ware (ATLAS.ti Scientific Software Development GmbH,
Germany). Data collected with the questionnaires
(demographic data and BSI) will be transferred to SPSS
(IBM SPSS Statistics Version 23.0, IBM Corp, Armonk,
NY, USA) for descriptive analyses of the data. Data entry
will be double checked.
No subject identifiers other than the subject’s assigned
unique study identifier will be contained in any of the
source data or in any of the data files, which will be
stored in the locked secure research servers or archive of
the research team of the University of Applied Sciences,
Department of Health Professions.
Data analysis
The content of the interviews will be independently ana-
lyzed by 2–3 members of the research team, using the-
matic analysis [39]. The codes are compared in joint
sessions to seek consensus. Thematic analysis first sum-
marizes the transcribed original text by dividing the text
into small units (paragraphs, sentences or phrases) that
will then be categorized. The categories will describe the
content of the interviews. During the analysis, members
of the research team will be blinded to individual data of
participants in the interviews and focus groups. The re-
search team will discuss the categories until they reach
consensus. Primary subcodes will be combined to super-
ior codes and these will be grouped to themes. Data will
be analyzed using ATLAS.ti software (ATLAS.ti Scien-
tific Software Development GmbH, Germany).
Ethical considerations
The study procedure includes single interviews with
formerly PMD affected women. A sensitive approach will
be taken to addressing and interviewing women who have
suffered from PMD, since they are potentially vulnerable.
For ethical reasons, we will interview only women who
have recovered from acute PMD and are stable for at least
12months before the interview.
If stressful emotions arise during interviews because
women recall negative memories [40], we will offer indi-
vidualized psychological support, provided by a profes-
sional contact person. If this professional considers
follow-up psychological support is necessary, the woman
will be referred to mental health care without delay. In-
terviewers will be health professionals (nurse, psycholo-
gist or midwife) who will be trained to perform the
interviews, and to recognize patterns of burden by the
study partners from psychiatry. All participants will be
informed that their contribution to this study is optional,
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and that they have the right to withdraw their consent at
any time. The anonymity of all information collected
through interviews and questionnaires is assured by cod-
ing and sufficient data aggregation.
Due to the subject of our study, stressful emotions
may also arise in participants of the focus groups or in
the interviewers. Participants of the focus group as well
as research assistants will have the opportunity to con-
tact a member of the study team to talk about it. Within
the research team, in regular meetings the personal well-
being with the study conduct will be addressed. The
study was approved by the responsible ethics committee.
Discussion
Expected results of the study
This study will identify strengths, weaknesses and gaps of
perinatal mental health care in Switzerland. Based on the
results we will propose recommendations to optimize
perinatal mental health care. We assume that our results
are relevant internationally i.e. for health care contexts of
other high income countries.
Strengths and possible limitations
Our study will be strengthened by our cooperation with
psychiatrists from the University of Bern, to ensure we
can recruit and interview women from this highly vul-
nerable population without further burdening them dur-
ing and after the interviews. Another strength of the
study is that we include patients who were diagnosed
based on ICD10 by a psychiatrist, while other studies
rely on self-assessment of patients [21].
Generalizability of our study results will be limited to
patients who received perinatal mental health care at the
University of Bern, Switzerland. Generalizability will also be
limited by responder bias, since we will include only former
patients with PMD who are interested in our research
topic. This purposive sample may also have its strengths,
since these women are highly motivated to report their ex-
periences and can provide us with competent statements.
Importance and benefits of the study
The high and growing burden of mental illness in the
perinatal period makes it necessary to reform health care
[41, 42]. This applies especially for women with PMD
because inadequate treatment can cause severe and
long-lasting harm for affected women, their children and
families [4, 43, 44] and high long-term costs for society
[8]. So far, we do not know enough how PMD patients
interact with mental health care, or which specific health
care needs are associated with PMD. Therefore, this
study will contribute to this highly relevant but under-
researched field of reproductive health care.
By considering a broad range of the most frequent and
most severe PMD the study will generate results which are
relevant for a wide range of different PMD patients and
across various health care settings. The wide interprofes-
sional approach of the focus groups and the combined per-
spectives of users and providers of health and social care
services will open up new perspectives of what is relevant
for adequate perinatal mental health care. The comprehen-
sive approach will identify barriers and facilitators that affect
access to care, timeliness and adequacy of care. Our data
will inform the design of innovative interdisciplinary models
of care – including advanced practice roles for nurses and
midwives. The data may inform the development of inter-
ventions and guidelines. The results and conclusion of the
study will be relevant for health care research and practice
in Switzerland and other high-income countries.
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